These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36943273)

  • 21. The APPROACH trial: Assessing pain, patient-reported outcomes, and complementary and integrative health.
    Zeliadt SB; Coggeshall S; Thomas E; Gelman H; Taylor SL
    Clin Trials; 2020 Aug; 17(4):351-359. PubMed ID: 32522024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ensuring transparency and minimization of methodologic bias in preclinical pain research: PPRECISE considerations.
    Andrews NA; Latrémolière A; Basbaum AI; Mogil JS; Porreca F; Rice ASC; Woolf CJ; Currie GL; Dworkin RH; Eisenach JC; Evans S; Gewandter JS; Gover TD; Handwerker H; Huang W; Iyengar S; Jensen MP; Kennedy JD; Lee N; Levine J; Lidster K; Machin I; McDermott MP; McMahon SB; Price TJ; Ross SE; Scherrer G; Seal RP; Sena ES; Silva E; Stone L; Svensson CI; Turk DC; Whiteside G
    Pain; 2016 Apr; 157(4):901-909. PubMed ID: 26683237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ethical challenges raised in the design and conduct of pragmatic trials: an interview study with key stakeholders.
    Nicholls SG; Carroll K; Zwarenstein M; Brehaut JC; Weijer C; Hey SP; Goldstein CE; Graham ID; Grimshaw JM; McKenzie JE; Fergusson DA; Taljaard M;
    Trials; 2019 Dec; 20(1):765. PubMed ID: 31870433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lessons learned in methods and analyses for pragmatic studies.
    Eckardt P; Erlanger AE
    Nurs Outlook; 2018 Sep; 66(5):446-454. PubMed ID: 30131168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pragmatic Clinical Trials in Osteoporosis.
    Adami G; Saag KG; Danila MI
    Curr Osteoporos Rep; 2019 Dec; 17(6):521-526. PubMed ID: 31773402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IMMPACT-recommended outcome measures and tools of assessment in burning mouth syndrome RCTs: an international Delphi survey protocol.
    Carey B; Farag AM; Nasri-Heir C; Klasser GD; Ariyawardana A; Chmieliauskaite M; Sardella A; Carlson CR; Miller CS; Mejia L; O'Neill FE; Albuquerque R
    Trials; 2020 Aug; 21(1):711. PubMed ID: 32787910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statistical Considerations for Embedded Pragmatic Clinical Trials in People Living with Dementia.
    Allore HG; Goldfeld KS; Gutman R; Li F; Monin JK; Taljaard M; Travison TG
    J Am Geriatr Soc; 2020 Jul; 68 Suppl 2(Suppl 2):S68-S73. PubMed ID: 32589276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How study designs influence comparative effectiveness outcomes: the case of oral versus long-acting injectable antipsychotic treatments for schizophrenia.
    Alphs L; Schooler N; Lauriello J
    Schizophr Res; 2014 Jul; 156(2-3):228-32. PubMed ID: 24842538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Responding to signals of mental and behavioral health risk in pragmatic clinical trials: Ethical obligations in a healthcare ecosystem.
    Ali J; Morain SR; O'Rourke PP; Wilfond B; O'Brien EC; Zigler CK; Staman KL; Weinfurt KP; Sugarman J
    Contemp Clin Trials; 2022 Feb; 113():106651. PubMed ID: 34998990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incentives and payments in pragmatic clinical trials: Scientific, ethical, and policy considerations.
    Garland A; Weinfurt K; Sugarman J
    Clin Trials; 2021 Dec; 18(6):699-705. PubMed ID: 34766524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of variability in the 7-day baseline pain diary on the assay sensitivity of neuropathic pain randomized clinical trials: an ACTTION study.
    Farrar JT; Troxel AB; Haynes K; Gilron I; Kerns RD; Katz NP; Rappaport BA; Rowbotham MC; Tierney AM; Turk DC; Dworkin RH
    Pain; 2014 Aug; 155(8):1622-1631. PubMed ID: 24831421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse Event Reporting in Clinical Trials of Intravenous and Invasive Pain Treatments: An ACTTION Systematic Review.
    Williams MR; McKeown A; Pressman Z; Hunsinger M; Lee K; Coplan P; Gilron I; Katz NP; McDermott MP; Raja SN; Rappaport BA; Rowbotham MC; Turk DC; Dworkin RH; Smith SM
    J Pain; 2016 Nov; 17(11):1137-1149. PubMed ID: 27522950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engaging Stakeholders in the Design and Conduct of Embedded Pragmatic Clinical Trials for Alzheimer's Disease and Alzheimer's Disease-Related Dementias.
    Harrison J; Maslow K; Tambor E; Phillips L; Frank L; Herndon L; Epstein-Lubow G
    J Am Geriatr Soc; 2020 Jul; 68 Suppl 2(Suppl 2):S62-S67. PubMed ID: 32589275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Readiness assessment for pragmatic trials (RAPT): a model to assess the readiness of an intervention for testing in a pragmatic trial.
    Baier RR; Jutkowitz E; Mitchell SL; McCreedy E; Mor V
    BMC Med Res Methodol; 2019 Jul; 19(1):156. PubMed ID: 31319789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pros and cons of pragmatic clinical trials.
    Lurie JD; Morgan TS
    J Comp Eff Res; 2013 Jan; 2(1):53-8. PubMed ID: 24236521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pilot and feasibility studies for pragmatic trials have unique considerations and areas of uncertainty.
    Chan CL; Taljaard M; Lancaster GA; Brehaut JC; Eldridge SM
    J Clin Epidemiol; 2021 Oct; 138():102-114. PubMed ID: 34229091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and Reporting Characteristics of Clinical Trials of Select Chronic and Recurrent Pediatric Pain Conditions: An Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks Systematic Review.
    Connolly MR; Chaudari JY; Yang X; Ward N; Kitt RA; Herrmann RS; Krane EJ; LeBel AA; Smith SM; Walco GA; Weisman SJ; Turk DC; Dworkin RH; Gewandter JS
    J Pain; 2019 Apr; 20(4):394-404. PubMed ID: 30219729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations.
    Dworkin RH; Turk DC; Wyrwich KW; Beaton D; Cleeland CS; Farrar JT; Haythornthwaite JA; Jensen MP; Kerns RD; Ader DN; Brandenburg N; Burke LB; Cella D; Chandler J; Cowan P; Dimitrova R; Dionne R; Hertz S; Jadad AR; Katz NP; Kehlet H; Kramer LD; Manning DC; McCormick C; McDermott MP; McQuay HJ; Patel S; Porter L; Quessy S; Rappaport BA; Rauschkolb C; Revicki DA; Rothman M; Schmader KE; Stacey BR; Stauffer JW; von Stein T; White RE; Witter J; Zavisic S
    J Pain; 2008 Feb; 9(2):105-21. PubMed ID: 18055266
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.